Arrow Financial Corp Vertex Pharmaceuticals Inc Transaction History

Arrow Financial Corp

$1.07 Billion
Q3 2024

A detailed history of Arrow Financial Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Arrow Financial Corp holds 5,595 shares of VRTX stock, worth $2.62 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

5,595

Previous 6,006 6.84%

Holding current value

$2.62 Million

Previous $2.82 Million 7.57%

% of portfolio

0.24%

Previous 0.28%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$460.0 - $505.78 $189,060 - $207,875	-411 Reduced 6.84%	5,595 $2.6 Million
Q2 2024 Jul 30, 2024	BUY	$392.81 - $485.53 $123,735 - $152,941	315 Added 5.54%	6,006 $2.82 Million
Q1 2024 May 21, 2024	BUY	$407.69 - $446.08 $954,809 - $1.04 Million	2,342 Added 69.93%	5,691 $2.38 Million
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $527,191 - $631,215	1,537 Added 84.82%	3,349 $1.36 Million
Q3 2023 Nov 09, 2023	BUY	$338.18 - $362.46 $504,564 - $540,790	1,492 Added 466.25%	1,812 $630,000
Q2 2023 Aug 09, 2023	BUY	$314.42 - $351.91 $3,773 - $4,222	12 Added 3.9%	320 $112,000
Q1 2023 May 03, 2023	SELL	$283.23 - $323.1 $566 - $646	-2 Reduced 0.65%	308 $97,000
Q4 2022 Feb 01, 2023	SELL	$285.76 - $321.48 $1,428 - $1,607	-5 Reduced 1.59%	310 $90,000
Q3 2020 Nov 06, 2020	SELL	$255.65 - $303.1 $5,113 - $6,062	-20 Reduced 5.97%	315 $86,000
Q1 2020 Apr 21, 2020	BUY	$199.77 - $247.81 $2,996 - $3,717	15 Added 4.69%	335 $79,000
Q3 2019 Oct 28, 2019	SELL	$166.23 - $187.09 $1,662 - $1,870	-10 Reduced 3.03%	320 $54,000
Q4 2017 Feb 05, 2018	BUY	$137.28 - $155.55 $4,118 - $4,666	30 Added 10.0%	330 $49,000
Q3 2017 Oct 18, 2017	BUY	$148.13 - $162.24 $44,439 - $48,672	300	300 $46,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Financial Corp with notifications on news.

Account

Arrow Financial Corp Vertex Pharmaceuticals Inc Transaction History